Department of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur, India.
Nanotechnology. 2010 Mar 26;21(12):125103. doi: 10.1088/0957-4484/21/12/125103. Epub 2010 Mar 2.
A low temperature polyol process, based on glycolaldehyde mediated partial reduction of FeCl(3).6H(2)O at 120 degrees C in the presence of sodium acetate as an alkali source and 2, 2(')-(ethylenedioxy)-bis-(ethylamine) as an electrostatic stabilizer has been used for the gram-scale preparation of biocompatible, water-dispersible, amine functionalized magnetite nanoparticles (MNPs) with an average diameter of 6 +/- 0.75 nm. With a reasonably high magnetization (37.8 e.m.u.) and amine groups on the outer surface of the nanoparticles, we demonstrated the magnetic separation and concentration implications of these ultrasmall particles in immunoassay. MRI studies indicated that these nanoparticles had the desired relaxivity for T(2) contrast enhancement in vivo. In vitro biocompatibility, cell uptake and MR imaging studies established that these nanoparticles were safe in clinical dosages and by virtue of their ultrasmall sizes and positively charged surfaces could be easily internalized by cancer cells. All these positive attributes make these functional nanoparticles a promising platform for further in vitro and in vivo evaluations.
一种基于乙二醇醛介导的三氯化铁部分还原的低温多元醇工艺,在 120°C 下,以乙酸钠作为碱源,2,2'-(乙二氧基)-双-(乙胺)作为静电稳定剂,用于克级制备生物相容、水分散性、胺功能化的磁铁矿纳米颗粒(MNPs),平均直径为 6 ± 0.75nm。这些超小颗粒具有相当高的磁化率(37.8 emu)和外表面的胺基团,我们证明了这些颗粒在免疫分析中的磁分离和浓缩作用。MRI 研究表明,这些纳米颗粒具有所需的弛豫率,可用于体内 T2 对比增强。体外生物相容性、细胞摄取和 MR 成像研究表明,这些纳米颗粒在临床剂量下是安全的,并且由于其超小尺寸和带正电荷的表面,很容易被癌细胞内化。所有这些积极的特性使这些功能纳米颗粒成为进一步进行体外和体内评估的有前途的平台。